Advanced Proteome Therapeutics CORP

Biotechnology company · Boston, Massachusetts, United States

Advanced Proteome Therapeutics CORP is a biotechnology company headquartered in Boston, Massachusetts, United States. It has reported private securities offerings to the US SEC, most recently $127,151 sold in a notice filed in 2020.

Profile compiled from public records. Is this your company? Request a correction or update

Advanced Proteome Therapeutics at a glance

Typebiotechnology company

HeadquartersBoston, Massachusetts, United States

SEC industryBiological Products, (No Diagnostic Substances)

SEC CIK1040368

What does Advanced Proteome Therapeutics do?

Private fundraising reported to the SEC

9 Form D notices; the most recent reported $127,151 sold (2020).

Frequently asked questions about Advanced Proteome Therapeutics

Where is Advanced Proteome Therapeutics headquartered?

Advanced Proteome Therapeutics CORP is headquartered in Boston, Massachusetts, United States.

What does Advanced Proteome Therapeutics do?

Advanced Proteome Therapeutics CORP is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

Similar companies

Syntis Bio, Inc.Boston, Massachusetts, United States
Strand Therapeutics Inc.Boston, Massachusetts, United States
Pear Therapeutics, Inc.Boston, Massachusetts, United States
Aura Biosciences, Inc.Boston, Massachusetts, United States
Holobiome, Inc.Boston, Massachusetts, United States
Leuko Labs, Inc.Boston, Massachusetts, United States
Compass Therapeutics, Inc.Boston, Massachusetts, United States
Odyssey Therapeutics, Inc.Boston, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences